13380 results for ""60+mice"+"6+weeks"+diet+study+2014+2017+DOI"

in 19.78 milliseconds.

• Tissue DNA, WBC DNA and cfDNA (deep-)sequencing of mCRC patients treated with doublet chemotherapy and anti-EGFR in the CAIRO5 study

  This study assessed whether ctDNA based treatment response monitoring could be performed in a tumor tissue-independent manner by combining ultra-deep targeted sequencing analyses of cfDNA with patient-matched white blood cell (WBC) derived DNA. In total, 183 cfDNA and 49 WBC samples, along with 28 tissue samples, from 52 metastatic colorectal cancer patients participating in the prospective phase III CAIRO5 clinical trial (NCT02162563) were analyzed using the PGDx elio plasma resolve assay.

  Study EGAS00001006695

• This study aims to evaluate the relationship between cardiometabolic risk factors and the most common genetic variation (SNPs)

  Comprehensive data on lifestyle-related modifiable factors, sociodemographic, anthropometric, economic, biochemical, and genetic markers related to the occurrence of cardiometabolic diseases as part of the observational cross-sectional survey “2015 Health Survey of Sao Paulo with Focus on Nutrition (2015 ISA-Nutrition)”, a population-based study. Data of 805218 SNPs for 841 individuals was genotyped using the Axiom™ 2.0 Precision Medicine Research Array in the Thermo Fisher Scientific laboratory (Affymetrix Inc, Santa Clara, CA).

  Study EGAS00001007818

• Cold Ischemia Study

  This study aimed to evaluate the impact of cold ischemia time on the expression of cancer-related genes, particularly those involved in hypoxia, apoptosis, and epithelial-to-mesenchymal transition (EMT). We performed RNA sequencing on 54 normal colon mucosa samples from nine patients undergoing colorectal cancer surgeries, freezing samples at predefined intervals ranging from 0 to 60 minutes. A total of 44 differentially expressed genes (DEGs) (p < 0.05) were identified when comparing samples frozen immediately (T0) with those frozen after 60 minutes (T5).

  Study EGAS00001008233

• Erasmus Rucphen Family Study

  Dac EGAC00001000295

• DAC for CancerLocator study

  Dac EGAC00001000602

• DAC for PROP1 study

  Dac EGAC00001000312

• DAC for ACC Study

  Dac EGAC00001000376

• DCIS-IDC study

  Dac EGAC00001000501

• The PREDO Study DAC

  Dac EGAC00001000511

• DAC for SCHoming study group

  Dac EGAC00001000667

• DAC for CancerDetector study

  Dac EGAC00001000979

• Nyamasati study access committee

  Dac EGAC00001001028

• Misoprostol study DAC

  Dac EGAC00001002213

• DAC of HER2 study

  Dac EGAC00001002288

• DAC for cfTrack study

  Dac EGAC00001002472

• DAC for study EGAS00001007291

  Dac EGAC00001003261

• Lifelines-NEXT newborn cohort

  Study EGAS00001007592

• Sequencing of Ovarian Cancer

  Study EGAS00001007489

• Sequencing of Breast Cancer

  Study EGAS00001007490

• ID1 in glioblastoma

  Study EGAS00001003711

• EAC Genomic data

  Study EGAS00001004887

• Retinal Dystrophy_analysis

  Study EGAS00001005369

• JEM 20211004R

  Study EGAS00001005764

• Acne GWAS meta-analysis

  Study EGAS00001005772

• PacBio Rare Disease Study - DAC

  Dac EGAC00001003560